Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

Historic Gross Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 100.0%.

  • ENDRA Life Sciences' Gross Margin changed N/A to 100.0% in Q1 2018 from the same period last year, while for Dec 2018 it was 100.0%, marking a year-over-year increase of 491400.0%. This contributed to the annual value of 100.0% for FY2018, which is 491400.0% up from last year.
  • According to the latest figures from Q1 2018, ENDRA Life Sciences' Gross Margin is 100.0%.
  • ENDRA Life Sciences' Gross Margin's 5-year high stood at 100.0% during Q1 2018, with a 5-year trough of 10.98% in Q2 2017.
  • For the 3-year period, ENDRA Life Sciences' Gross Margin averaged around 55.8%, with its median value being 54.96% (2017).
  • Data for ENDRA Life Sciences' Gross Margin shows a peak YoY increase of 7100bps (in 2017) and a maximum YoY decrease of 7100bps (in 2017) over the last 5 years.
  • Over the past 3 years, ENDRA Life Sciences' Gross Margin (Quarter) stood at 54.25% in 2016, then rose by 1bps to 54.96% in 2017, then surged by 82bps to 100.0% in 2018.
  • Its Gross Margin stands at 100.0% for Q1 2018, versus 54.96% for Q4 2017 and 58.79% for Q3 2017.